TriGalNAc CBz

CAS No. 186613-57-0

TriGalNAc CBz( —— )

Catalog No. M37133 CAS No. 186613-57-0

TriGalNAc CBz is a GalNAc derivative. As an ASGPR ligand, tri-GalNAc targets lysosomes in mRNA drug delivery and LYTAC studies.L-DABA hydrobromide.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 46 Get Quote
5MG 61 Get Quote
10MG 93 Get Quote
25MG 182 Get Quote
50MG 306 Get Quote
100MG 484 Get Quote
500MG 1035 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    TriGalNAc CBz
  • Note
    Research use only, not for human use.
  • Brief Description
    TriGalNAc CBz is a GalNAc derivative. As an ASGPR ligand, tri-GalNAc targets lysosomes in mRNA drug delivery and LYTAC studies.L-DABA hydrobromide.
  • Description
    TriGalNAc CBz is a GalNAc derivative and tri-GalNAc is an asialoglycoprotein receptor (ASGPR) ligand. TriGalNAc CBz can be used for mRNA drug delivery as well as lysosomal targeted chimerism (LYTAC) studies.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    LYTACs
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    186613-57-0
  • Formula Weight
    633.64
  • Molecular Formula
    C34H35NO11
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (157.82 mM; Ultrasonic (<60°C)
  • SMILES
    O(C(=O)C1=CC=CC=C1)[C@H]2[C@@H](OC(=O)C3=CC=CC=C3)[C@@H](COC(=O)C4=CC=CC=C4)O[C@@H](OCCCCC(O)=O)[C@@H]2NC(C)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kallanthottathil G. Rajeev, et al. Compositions and methods for targeted rna delivery. WO2021178725.
molnova catalog
related products
  • Mukanadin C

    Mukanadin C is a marine derived natural products found in Stylissa carteri.

  • Arjunglucoside II

    Arjunglucoside II exhibits a moderate free radical scavenging activity.

  • Cucurbit

    Cucurbit[7]uril is an emerging candidate for pharmaceutical excipients.Cucurbit[7]uril enhances photosensitization of porphyrins in Neuroblastoma cells.